BMS, CBS Focus on PAT to Save Biopharm Big Bucks

In September, a new Center for Bioanalytical Sciences will start up, involving Bristol-Myers Squibb Co., Dublin City University and the National University of Ireland, Galway. BMS predicts the technologies being developed could reduce biopharmaceutical production costs by $80 million per year for a typical medium to large processing line.